https://pdgfrsignal.com/index.....php/multidimensional
Immunohistochemical assays for CXCL-12 and CDX-2 expression were performed using the primary antibodies Anti-CXCL-12 (MA5-23759) and Anti-CDX-2 (EP25), respectively. In patients treated with the drug under investigation, there was a statistically significant growth in the number of glands per millimeter. The gastric mucosa's attributes displayed a significant elevation, reaching 261%
Like
Comment
Share
